Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-20

Clinical Trial Update: Clinical Efficacy of Single-Use of Peroxyl Mouthwash for Reducing Bacteria Saliva and Bioaerosol Contamination Phase 2 [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy of a single use of Peroxyl Mouthwash in reducing oral bacteria, saliva, and bioaerosol contamination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Peroxyl Mouthwash

Snippet

Sponsor: Colgate Palmolive | Conditions: Healthy | Phase 2 | Status: COMPLETED